Viru-Chord
- Manufacturer
- Energetix Corp
- Effective date
- 2017-12-19
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-06-01 02:09:01
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active Ingredients (per drop) Belladonna 12X, 30X; Cinchona 12X; Echinacea 4X; Gelsemium 6X; Glandula suprarenalis suis 9X, 12X, 6C; Glycyrrhiza 4X; Hepar suis 9X, 12X, 6C; Hydrastis 4X; Illicium 12X; Influenzinum 30X; Lachesis 12X; Lappa 4X; Mag phos 12X; Morbillinum 30X; Myrrha 4X, 6X; Nasturtium 6X; Nux vom 12X; Paloondo 12X; Pyridoxinum hydrochloricum 12X, 30X; Riboflavinum 12X, 30X; Sambucus nig 4X, 6X; Scutellaria 6X; Thiaminum hydrochloricum 12X, 30X; Thyroidinum 9X, 12X, 6C
INDICATIONS & USAGE SECTION
Uses Temporary relief of fever, fatigue, diarrhea, muscle aches, nausea.
These statements have not been reviewed by the Food and Drug Administration.
WARNINGS SECTION
Warnings
- In case of overdose, get medical help or contact a Poison Control Center right away.
- If pregnant or breast feeding, ask a health professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
- KEEP OUT OF REACH OF CHILDREN.
DOSAGE & ADMINISTRATION SECTION
Directions
- Take 30 drops orally twice daily or as directed by a healthcare professional.
- Consult a physician for use in children under 12 years of age or if symptoms worsen or persist.
OTHER SAFETY INFORMATION
Other Information
- Store at room temperature out of direct sunlight.
- Do not use if neck wrap seal is broken or missing.
- Shake well before use.
INACTIVE INGREDIENT SECTION
Inactive Ingredients Ethyl Alcohol, Glycerin, Purified Water.
OTC - QUESTIONS SECTION
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
energetix
VIRU-CHORD
HomeopathicRemedy
fever, fatigue, diarrhea, muscle aches, nausea.
2 fl oz (59.1 mL) / 15% Ethyl Alcohol
OTC - PURPOSE SECTION
Relief of fever, fatigue, diarrhea, muscle aches, nausea.
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| cf050ccd-1144-f76a-e00d-e5698d8597d4 | Product name | 6 | 20250625 |
| 59361619-24d9-b610-eca6-5a7f25ed5e03 | Product name | 5 | 20240909 |
| 5e18e798-5614-cf5c-0185-38b1cb77a093 | Product name | 2 | 20160822 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 64578-0078-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-1870-f424-e053-dadaa90a57ce | Viru-Chord |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 64578-0078-1 | Viru-Chord | 59.1 mL in 1 BOTTLE, DROPPER | LIQUID | 59.1 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 64578-0078 | VIRU-CHORD (HOMEOPATHIC LIQUID) LIQUID [ENERGETIX CORP] | 2 | Legacy NDC, 1 package rows | 20171222_7e360b6b-6d9f-4130-a677-962020bff245.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ARCTIUM LAPPA ROOT | ACTIVE INGREDIENT | 597E9BI3Z3 | 1 | |
| ATROPA BELLADONNA | ACTIVE INGREDIENT | WQZ3G9PF0H | 1 | |
| CINCHONA OFFICINALIS BARK | ACTIVE INGREDIENT | S003A158SB | 1 | |
| ECHINACEA ANGUSTIFOLIA | ACTIVE INGREDIENT | VB06AV5US8 | 1 | |
| GELSEMIUM SEMPERVIRENS ROOT | ACTIVE INGREDIENT | 639KR60Q1Q | 1 | |
| GLYCYRRHIZA GLABRA | ACTIVE INGREDIENT | 2788Z9758H | 1 | |
| GOLDENSEAL | ACTIVE INGREDIENT | ZW3Z11D0JV | 1 | |
| INFLUENZA A VIRUS | ACTIVE INGREDIENT | R9HH0NDE2E | 1 | |
| INFLUENZA B VIRUS | ACTIVE INGREDIENT | 1314JZ2X6W | 1 | |
| LACHESIS MUTA VENOM | ACTIVE INGREDIENT | VSW71SS07I | 1 | |
| LARREA TRIDENTATA TOP | ACTIVE INGREDIENT | PK0TXD049P | 1 | |
| MAGNESIUM PHOSPHATE, DIBASIC | ACTIVE INGREDIENT | A1Y870209Z | 1 | |
| MEASLES VIRUS | ACTIVE INGREDIENT | HT3R7C012Q | 1 | |
| MYRRH | ACTIVE INGREDIENT | JC71GJ1F3L | 1 | |
| NASTURTIUM AQUATICUM | ACTIVE INGREDIENT | YH89GMV676 | 1 | |
| PORK LIVER | ACTIVE INGREDIENT | 6EC706HI7F | 1 | |
| PYRIDOXINE HYDROCHLORIDE | ACTIVE INGREDIENT | 68Y4CF58BV | 1 | |
| RIBOFLAVIN | ACTIVE INGREDIENT | TLM2976OFR | 1 | |
| SAMBUCUS NIGRA FLOWERING TOP | ACTIVE INGREDIENT | CT03BSA18U | 1 | |
| SCUTELLARIA LATERIFLORA | ACTIVE INGREDIENT | 7BP4DH5PDC | 1 | |
| STAR ANISE | ACTIVE INGREDIENT | XKC1657P78 | 1 | |
| STRYCHNOS NUX-VOMICA SEED | ACTIVE INGREDIENT | 269XH13919 | 1 | |
| SUS SCROFA ADRENAL GLAND | ACTIVE INGREDIENT | 398IYQ16YV | 1 | |
| THIAMINE HYDROCHLORIDE | ACTIVE INGREDIENT | M572600E5P | 1 | |
| THYROID, UNSPECIFIED | ACTIVE INGREDIENT | 0B4FDL9I6P | 1 | |
| ARCTIUM LAPPA ROOT | ACTIVE MOIETY | 597E9BI3Z3 | 1 | |
| ATROPA BELLADONNA | ACTIVE MOIETY | WQZ3G9PF0H | 1 | |
| CINCHONA OFFICINALIS BARK | ACTIVE MOIETY | S003A158SB | 1 | |
| ECHINACEA ANGUSTIFOLIA | ACTIVE MOIETY | VB06AV5US8 | 1 | |
| GELSEMIUM SEMPERVIRENS ROOT | ACTIVE MOIETY | 639KR60Q1Q | 1 | |
| GLYCYRRHIZA GLABRA | ACTIVE MOIETY | 2788Z9758H | 1 | |
| GOLDENSEAL | ACTIVE MOIETY | ZW3Z11D0JV | 1 | |
| INFLUENZA A VIRUS | ACTIVE MOIETY | R9HH0NDE2E | 1 | |
| INFLUENZA B VIRUS | ACTIVE MOIETY | 1314JZ2X6W | 1 | |
| LACHESIS MUTA VENOM | ACTIVE MOIETY | VSW71SS07I | 1 | |
| LARREA TRIDENTATA TOP | ACTIVE MOIETY | PK0TXD049P | 1 | |
| MAGNESIUM PHOSPHATE, DIBASIC | ACTIVE MOIETY | A1Y870209Z | 1 | |
| MEASLES VIRUS | ACTIVE MOIETY | HT3R7C012Q | 1 | |
| MYRRH | ACTIVE MOIETY | JC71GJ1F3L | 1 | |
| NASTURTIUM AQUATICUM | ACTIVE MOIETY | YH89GMV676 | 1 | |
| PORK LIVER | ACTIVE MOIETY | 6EC706HI7F | 1 | |
| PYRIDOXINE | ACTIVE MOIETY | KV2JZ1BI6Z | 1 | |
| RIBOFLAVIN | ACTIVE MOIETY | TLM2976OFR | 1 | |
| SAMBUCUS NIGRA FLOWERING TOP | ACTIVE MOIETY | CT03BSA18U | 1 | |
| SCUTELLARIA LATERIFLORA | ACTIVE MOIETY | 7BP4DH5PDC | 1 | |
| STAR ANISE | ACTIVE MOIETY | XKC1657P78 | 1 | |
| STRYCHNOS NUX-VOMICA SEED | ACTIVE MOIETY | 269XH13919 | 1 | |
| SUS SCROFA ADRENAL GLAND | ACTIVE MOIETY | 398IYQ16YV | 1 | |
| THIAMINE ION | ACTIVE MOIETY | 4ABT0J945J | 1 | |
| THYROID, UNSPECIFIED | ACTIVE MOIETY | 0B4FDL9I6P | 1 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- Viru-Chord
- Homeopathic Liquid
- ATROPA BELLADONNA
- CINCHONA OFFICINALIS BARK
- ECHINACEA ANGUSTIFOLIA
- GELSEMIUM SEMPERVIRENS ROOT
- SUS SCROFA ADRENAL GLAND
- GLYCYRRHIZA GLABRA
- PORK LIVER
- GOLDENSEAL
- STAR ANISE
- INFLUENZA A VIRUS
- INFLUENZA B VIRUS
- LACHESIS MUTA VENOM
- ARCTIUM LAPPA ROOT
- MAGNESIUM PHOSPHATE, DIBASIC
- MEASLES VIRUS
- MYRRH
- RORIPPA NASTURTIUM-AQUATICUM
- LARREA TRIDENTATA TOP
- STRYCHNOS NUX-VOMICA SEED
- PYRIDOXINE HYDROCHLORIDE
- PYRIDOXINE
- RIBOFLAVIN
- SAMBUCUS NIGRA FLOWERING TOP
- SCUTELLARIA LATERIFLORA
- THIAMINE HYDROCHLORIDE
- THIAMINE ION
- THYROID, UNSPECIFIED
- WATER
- ALCOHOL
- GLYCERIN
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 64578-0078 | 64578-0078-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYRUP / ORAL | 16734 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVESICAL | 7892 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, EXTENDED RELEASE / ORAL | 265 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DOUCHE / VAGINAL | 1 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVASCULAR | 100 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, FILM COATED / ORAL | 1.55 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / AURICULAR (OTIC) | 25 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GUM, CHEWING / BUCCAL | 230 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SHAMPOO / TOPICAL | 5 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / AURICULAR (OTIC) | 63.64 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / OPHTHALMIC | 3 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / RESPIRATORY (INHALATION) | 5 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / ORAL | 26208 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / OPHTHALMIC | 0.88 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / TOPICAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / VAGINAL | 227.9 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TOPICAL | 9971 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LOTION / TOPICAL | 25 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | ELIXIR / ORAL | 5621 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | MOUTHWASH / BUCCAL | 100 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, LIQUID FILLED / ORAL | 185 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAVENOUS | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / OPHTHALMIC | 12 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, COATED / ORAL | 14.21 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / TOPICAL | 561 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / SUBCUTANEOUS | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE, DENTIFRICE / DENTAL | 18 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / INTRAVENOUS | 4000 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, EMULSION / INTRAVENOUS | 520 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / VAGINAL | 60 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAMUSCULAR | 450 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVENOUS | 92 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 35.75 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 225 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| a66039c4-de46-4036-b189-05a79646639b | 7e360b6b-6d9f-4130-a677-962020bff245 | 2017-12-19 | Warnings | a66039c4-de46-4036-b189-05a79646639b 7e360b6b-6d9f-4130-a677-962020bff245 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
